scispace - formally typeset
D

Dina Lev

Researcher at University of Texas MD Anderson Cancer Center

Publications -  153
Citations -  13902

Dina Lev is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Sarcoma. The author has an hindex of 56, co-authored 152 publications receiving 12002 citations. Previous affiliations of Dina Lev include University of Texas at Austin & University of Texas Health Science Center at Houston.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors

Alexander J. Lazar, +9 more
- 01 Nov 2008 - 
TL;DR: Patients harboring CTNNB1 (45F) mutations are at particular risk for recurrence and therefore may especially benefit from adjuvant therapeutic approaches.
Journal ArticleDOI

Outcome Prediction in Primary Resected Retroperitoneal Soft Tissue Sarcoma: Histology-Specific Overall Survival and Disease-Free Survival Nomograms Built on Major Sarcoma Center Data Sets

Alessandro Gronchi, +12 more
- 01 May 2013 - 
TL;DR: These nomograms accurately predict postoperative overall survival (OS) and disease-free survival (DFS) in patients with primary RPS and should be used for patient counseling in clinical practice and stratification in clinical trials.
Journal ArticleDOI

Optimizing Treatment of Desmoid Tumors

Dina Lev, +9 more
- 01 May 2007 - 
TL;DR: Increased awareness of the complex multidisciplinary management needed for desmoid tumor control may underlie significantly increased numbers of referrals to UTMDACC, especially primary untreated desmoids.
Journal ArticleDOI

Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.

Changye Zou, +11 more
- 01 Jun 2009 - 
TL;DR: MPSNT is a markedly metastatic and aggressive poor prognosis tumor and multiple clinical, pathologic, and molecular markers identified in this study, coupled with findings from previous series, should be considered for an improved MPNST staging system useful for prognostic assessment and management decisions.